<p>Data shown are median and range, except specified. CR: Complete remission; CSF: Cerebrospinal fluid; PR: Partial remission; WBC: White blood cells. Normal values: CSF WBC, 0–8 ×10<sup>6</sup>/L; CSF proteins, 0.15–0.45 g/L; CSF IgG, 0–34 mg/l. *P<0.05 vs. the HC.</p><p>The demographic and clinical features of 12 MS patients after treatment.</p
<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F =...
<p>Differences in CSF lymphocyte populations and clinical parameters between MS patients with (SPMS ...
<p>Data are expressed as mean (standard deviation) unless otherwise stated. <sup>a</sup>Data are exp...
<p>Data shown are median and range, except specified. ARR: Annual relapse rate; EDSS: Expanded disab...
<p>Data shown are median and range, except specified. CSF: Cerebrospinal fluid; MBP-Ab: Antibodies a...
a<p>Median number of years from first symptoms of MS to inclusion.</p>b<p>Treatment within 4 months ...
<p>Table 2 shows the demographics and clinical data of the patient cohort. These demographic and cli...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
1<p>Two or more oligoclonal bands in CSF at isoelectric focusing that were not present in serum.</p>...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
<p>Data are expressed as median and range (in brackets). There were no statistically significant dif...
<p>These patients had the classic characteristics of MS populations: F/M sex ratio 2.47 (19,656/7,94...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Average ± SEM are shown; EDSS: Kurtzke Expanded Disability Status Scale; RR: relapsing-remitting ...
<p>Data are expressed as number or median (25<sup>th</sup>–75<sup>th</sup> percentile).</p><p>N = nu...
<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F =...
<p>Differences in CSF lymphocyte populations and clinical parameters between MS patients with (SPMS ...
<p>Data are expressed as mean (standard deviation) unless otherwise stated. <sup>a</sup>Data are exp...
<p>Data shown are median and range, except specified. ARR: Annual relapse rate; EDSS: Expanded disab...
<p>Data shown are median and range, except specified. CSF: Cerebrospinal fluid; MBP-Ab: Antibodies a...
a<p>Median number of years from first symptoms of MS to inclusion.</p>b<p>Treatment within 4 months ...
<p>Table 2 shows the demographics and clinical data of the patient cohort. These demographic and cli...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
1<p>Two or more oligoclonal bands in CSF at isoelectric focusing that were not present in serum.</p>...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
<p>Data are expressed as median and range (in brackets). There were no statistically significant dif...
<p>These patients had the classic characteristics of MS populations: F/M sex ratio 2.47 (19,656/7,94...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Average ± SEM are shown; EDSS: Kurtzke Expanded Disability Status Scale; RR: relapsing-remitting ...
<p>Data are expressed as number or median (25<sup>th</sup>–75<sup>th</sup> percentile).</p><p>N = nu...
<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F =...
<p>Differences in CSF lymphocyte populations and clinical parameters between MS patients with (SPMS ...
<p>Data are expressed as mean (standard deviation) unless otherwise stated. <sup>a</sup>Data are exp...